Current and emerging strategies for treatment of childhood dystonia

Matteo Bertucco1, Terence D Sanger2

  • 1Department of Biomedical Engineering, University of Southern California, Los Angeles, CA, USA.

Insights

Childhood dystonia, a movement disorder, causes involuntary muscle contractions and abnormal postures in children. This review explores its neurophysiology, measurement tools, and innovative therapeutic strategies.

Area of Science:

  • Neurology
  • Pediatrics
  • Movement Disorders

Background:

  • Childhood dystonia is a neurological condition causing involuntary muscle contractions, abnormal postures, and impaired motor skill acquisition during development.
  • It is particularly debilitating when affecting upper extremities, hindering daily motor actions and learning.
  • Effective treatment and rehabilitation remain challenging, necessitating novel interventions.

Purpose of the Study:

  • To review the neurophysiological mechanisms underlying motor impairments in childhood dystonia.
  • To discuss available clinical measurement tools for assessing dystonia symptoms.
  • To explore current and emerging therapeutic strategies for childhood dystonia.

Main Methods:

  • Literature review of neurophysiological mechanisms.
  • Analysis of clinical measurement tools for dystonia assessment.
  • Discussion of state-of-the-art and innovative therapeutic options.

Main Results:

  • Childhood dystonia involves complex neurophysiological alterations affecting motor control.
  • Various clinical tools exist to quantify dystonia severity and impact.
  • Emerging therapies show promise for improved treatment outcomes.

Conclusions:

  • Understanding neurophysiology is key to developing targeted treatments for childhood dystonia.
  • Accurate assessment tools are crucial for monitoring treatment efficacy.
  • Innovative therapeutic strategies offer new hope for managing this debilitating condition.

Related Concept Videos

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
1.4K
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.2K
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
948
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Centrally Acting Muscle Relaxants: Therapeutic Uses01:24

Centrally Acting Muscle Relaxants: Therapeutic Uses

Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
1.6K
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
2.1K